| Code | 2607A | ||||||||||
| MA number | EU/1/12/775/001 | ||||||||||
| Product Form: | plv iol 1x2500 IU+1x3,2 ml solv. (liek.inj.skl+adaptér) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Novo Nordisk A/S, Denmark | ||||||||||
| Therapeutic Class: | 23 - ANTIHAEMORRHOIDALIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 03.09.2012 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 27.01.2021 |
